![JNIS Podcast artwork](https://is1-ssl.mzstatic.com/image/thumb/Podcasts122/v4/4a/29/5b/4a295b9e-f14f-72a9-3814-d74825d3cc3f/mza_7832370724770329734.png/100x100bb.jpg)
Neucrylate - a new treatment for berry aneuryms
JNIS Podcast
English - April 23, 2013 15:21 - 13 minutes - 12.3 MB - ★★★★★ - 14 ratingsScience Health & Fitness Medicine aneurysm stroke vascular malformation brain spine treatment cost efficacy Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
JNIS editor Rob Tarr talks to Charles Kerber (University of California San Diego Medical Center) about Neucrylate, a new treatment for berry aneurysms.
Dr Kerber describes how his company developed the liquid embolic device, the results they’ve had using it, and future plans to get it into practice.
See also:
1-Hexyl n-cyanoacrylate compound (Neucrylate™ AN), a new berry aneurysm treatment. II. Rabbit implant studies: technique and histology http://bit.ly/17g34e7
1-Hexyl n-cyanoacrylate compound (Neucrylate™ AN), a new berry aneurysm treatment. I. Theoretical basis and laboratory evaluation http://bit.ly/YKON3y
1-Hexyl n-cyanoacrylate compound (Neucrylate™ AN), a new treatment for berry aneurysm. III: Initial clinical results http://bit.ly/10wAIx4